Literature DB >> 15655441

Is removal of internal limiting membrane always necessary during stage 3 idiopathic macular hole surgery?

Tetsushi Kimura1, Masayo Takahashi, Hitoshi Takagi, Junichi Kiryu, Hirokazu Nishiwaki, Teruyo Tanabe, Kiyoshi Suzuma, Hideyasu Oh, Yoshihito Honda.   

Abstract

PURPOSE: To determine the indications for internal limiting membrane (ILM) removal in stage 3 idiopathic macular holes (MHs).
METHODS: Focal posterior vitreous detachments (PVDs) at MH rims were examined preoperatively by optical coherence tomography and binocular slit-lamp fundus examination in 19 patients retrospectively. All eyes underwent pars plana vitrectomy and creation of a PVD, and some eyes underwent a second surgery to remove the ILM. Indications of ILM removal for MH closure were discussed.
RESULTS: Preoperatively, 9 eyes did not (non-PVD group) and 10 eyes did (PVD group) have complete focal PVDs. In all nine eyes in the non-PVD group, MHs were closed after the creation of a PVD without ILM peeling (P <0.05, chi test). In the PVD group, 5 eyes (50%) had MHs closed by making PVD complete without ILM removal, and 5 eyes (50%) required ILM removal in a second surgery. In the end, closure of MHs was achieved in all eyes.
CONCLUSION: Anatomic closure of stage 3 idiopathic MHs without a PVD at the rim of the hole may be achieved only by creating a PVD without ILM removal.

Entities:  

Mesh:

Year:  2005        PMID: 15655441     DOI: 10.1097/00006982-200501000-00007

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Macular hole surgery with short-acting gas and short-duration face-down positioning.

Authors:  Tina Xirou; Panagiotis G Theodossiadis; Michael Apostolopoulos; Stamatina A Kabanarou; Elias Feretis; Ioannis D Ladas; Chrysanthi Koutsandrea
Journal:  Clin Ophthalmol       Date:  2012-07-20

2.  Combined pars plana lensectomy/vitrectomy for idiopathic macular hole repair without postoperative prone positioning.

Authors:  Nicola G Ghazi; Armand Daccache; Robert Knape; James S Tiedeman
Journal:  Digit J Ophthalmol       Date:  2008-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.